This recap of Episode 87 of Cell & Gene: The Podcast shares Neogene Therapeutics' Carsten Linnemann, Ph.D.'s take on why "off-the-shelf" will make t-cell receptor therapies more accessible to patients.
- Imbalance In The CDMO Market And The Long-Term Implications
- A Comprehensive Guide For Supplier Quality Agreements
- Aligning Sterile Filtration With EU GMP Guide Annex 1 Standards
- Safety Cabinets' Essential Role In EU GMP Annex 1
- Highlights From ARM's 2024 Meeting On The Mesa
- Life Sciences Cybersecurity Incident Management: The End-to-End Approach
- Cell & Gene Therapies: Avoid This Common Pitfall In Supply Chain Planning
- Exploring Sanofi R&D's Batch Monitoring Initiative
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Compatible Platforms For Microbial Identification
Reduce the time-to-results for microbial identification by taking advantage of the shorter run cycle and off-instrument data analysis provided by this optimized and validated workflow.
-
Development Of A Novel Cell Culture Medium For AAV Production
Explore the medium development process of a novel cell culture medium for AAV production with multiple HEK293 lineages, which was performed with three different HEK293 cell lines to maximize AAV titers.
-
Comprehensive Peptide Mapping Of Protein Therapeutics
Explore how the peptide mapping workflows templates provided by a software designed for the characterization of biotherapeutic digests alongside data visualization and interrogation.
-
Expert Insights In Navigating CGT's Complex Supply Chain
Examine insights shared during Cencora's ThinkLive Cell and Gene Therapy Summit 2024 that shed light on the challenges and opportunities in navigating the complexities of the cell and gene supply chain.
-
High Yield Protein Production System For Suspension CHO Cells
Reduced the risk of contamination caused by repeated handling of the culture during transient protein production in suspension CHO cells.
-
Precision Oncology Clinical Trials And Statistics 2024
Delve into the latest advancements in clinical trials, targeted therapies, and the promising future of cancer care, uncovering innovative treatments shaping oncology.
-
Peanut Allergy: Asia Pacific Clinical Trial Landscape
Explore the differences between the common food allergies in Asia and the West, specifically the peanut allergy.
-
Rapid High-Resolution Screening Of Plasma B Cells to Identify Antibody Lead Candidates
View demonstrations of adherent cell-based assays developed for the discovery of antibodies against challenging targets that can neither be expressed in soluble form nor in suspension cells.
-
Highly Sensitive ELISAs In 90 Minutes
Traditional ELISA methods are often limited by their relatively low throughput and need for multiple wash steps. Learn about a solution that overcomes these challenges and provides rapid results.
-
Biotechnology Manufacturing Program Management
Find out how a global biotechnology manufacturing company executing several interrelated projects achieved critical project objectives while adhering to schedule and financial commitments.
NEWSLETTER ARCHIVE
- 11.01.24 -- Accelerate Your Cell And Gene Therapy Research
- 11.01.24 -- Pioneering Next-Gen TCR Therapies In Solid Tumors
- 10.31.24 -- Key Considerations For Aseptic Filling
- 10.31.24 -- Considering Serialization Processes When Choosing A CDMO Or 3PL
- 10.30.24 -- Navigate Regulatory Landscapes In Your mRNA Drug Development
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections